Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population

Journal of Hypertension

Volumn 29, Issue 6, 2011, Pages 1121-1127

  Grassi, Guido ^a,b   Padmanabhan, Sandosh ^c   Menni, Cristina ^a,b,c   Seravalle, Gino ^d   Lee, Wai K ^c   Bombelli, Michele ^a,b   Brambilla, Gianmaria ^e   Quarti Trevano, Fosca ^a,b   Giannattasio, Cristina ^a,b   Cesana, Giancarlo ^c   Dominiczak, Anna ^a,b   Mancia, Giuseppe ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^e IRCCS MULTIMEDICA   (Italy)

Author keywords

association; genetics; metabolic syndrome; microneurography; sympathetic nervous system

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; EFFERENT NERVE; FEMALE; GENETIC ASSOCIATION; GOLD STANDARD; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MUSCLE INNERVATION; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 79955624342     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328346d72c     Document Type: Article

References (41)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
2. Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, Mancia G. Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European Society of Hypertension position statement. J Hypertens 2008; 26:1891-1900.
3. Freeman MS,Mansfield MW, Barrett JH, Grant PJ. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 2002; 19:994-999. (Pubitemid 35471967)
4. Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco RL. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005; 48:2006-2012. (Pubitemid 41416910)
5. Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, et al. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 2006; 55:1985-1994. (Pubitemid 44509971)
6. Hoffmann K, Mattheisen M, Dahm S, Nurnberg P, Roe C, Johnson J, et al. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia 2007; 50:1418-1422. (Pubitemid 46878999)
7. Edwards KL, Hutter CM, Wan JY, Kim H, Monks SA. Genome-wide linkage scan for the metabolic syndrome: the GENNID study. Obesity 2008; 16:1596-1601. (Pubitemid 351915107)
8. An P, Freedman BI, Hanis CL, Chen YD, Weder AB, Schork NJ, et al. Genome-wide linkage scans for fasting glucose, insulin, and insulin resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: evidence of linkages to chromosome 7q36 and 19q13 from meta-analysis. Diabetes 2005; 54:909-914. (Pubitemid 40322098)
9. Kraja AT, Hunt SC, Pankow JS, Myers RH, Heiss G, Lewis CE, et al. Quantitative trait loci for metabolic syndrome in the Hypertension Genetic Epidemiology Network study. Obes Res 2005; 13:1885-1890.
10. Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 2006; 3:482-489. (Pubitemid 44288461)
11. Wilcox M, Li Q, Sun Y, Stang P, Berlin J, Wang D. Genome-wide association study for empirically derived metabolic phenotypes in the Framingham Heart Study offspring cohort. BMC Proc 2009; 3:S53.
12. Park YM, Province MA, Gao X, Feitosa M, Wu J, Ma D, et al. Longitudinal trends in the association of metabolic syndrome with 550 k singlenucleotide polymorphisms in the Framingham Heart Study. BMC Proc 2009; 3:S116.
13. Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004; 44:847-852. (Pubitemid 39577410)
14. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005; 48:1359-1365. (Pubitemid 41186102)
15. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90:5998-6005. (Pubitemid 41606517)
16. Reja V, Goodchild AK, Pilowsky PM. Catecholamine-related gene expression correlates with blood pressures in SHR. Hypertension 2002; 40:342-347. (Pubitemid 35006721)
17. Snapir A, Koskenvuo J, Toikka J, Orho-Melander M, Hinkka S, Saraste M, et al. Effects of common polymorphisms in the alpha1A, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline. Clin Sci 2003; 104:509-520. (Pubitemid 36628147)
18. Padmanabhan S, Menni C, Lee WK, Laing S, Brambilla P, Sega R, et al. The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study. J Hypertens 2010; 28:465-477.
19. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390. (Pubitemid 26015753)
20. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007; 49:40-47. (Pubitemid 46360339)
21. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988; 41:105-114.
22. Mancia G, Facchetti R, Bombelli M, Polo FH, Grassi G, Giannattasio C, Sega R. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005; 45:1072-1077. (Pubitemid 40770307)
23. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285:2486-2497.
24. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92:3206-3211.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575. (Pubitemid 47330214)
26. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96:434-442. (Pubitemid 38443646)
27. Benjamini Y, Yekutieli D. Quantitative trait loci analysis using the false discovery rate. Genetics 2005; 171:783-790. (Pubitemid 43156463)
28. Grassi G, Quarti-Trevano F, Seravalle G, Dell'Oro R, Dubini A, Mancia G. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome. Metabolism 2009; 58:1446-1451.
29. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25:909-920. (Pubitemid 46573105)
30. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54:690-697.
31. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14:103S-115S. (Pubitemid 32506704)
32. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-381. (Pubitemid 26049592)
33. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106:2533-2536. (Pubitemid 35340687)
34. Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, Mancia G. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97:2037-2042. (Pubitemid 28243666)
35. Wu H, Tang W, Li H, Zhou X, Jang H, Yu H, et al. Association of the beta2- adrenergic receptor gene with essential hypertension in the non-Han Chinese Yi minority human population. J Hypertens 2006; 24:1041-1047. (Pubitemid 43772311)
36. Freitas SR, Pereira AC, Floriano MS, Mill JG, Krieger JE. Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in Brazilian population. BMC Cardiovasc Disord 2008; 8:40.
37. Mancia G, Bombelli M, Facchetti R, Casati A, Ronchi I, Quarti-Trevano F, et al. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events. J Hypertens 2010; 28:999-1006.
38. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17:719-734. (Pubitemid 29322156)
39. Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, et al. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 1993; 11:1217-1227. (Pubitemid 23330079)
40. Berridge CW. Noradrenergic modulation of arousal. Brain Res Rev 2008; 58:1-17.
41. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. Br Med J 2006; 332:521-525.